Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Guide Therapeutics

Explore full profile

Pioneering gene therapy with DNA barcoding, unlocking new nanoparticles for precise drug delivery and breakthrough treatments

Tucker, United StatesFounded 2018Biotech & Life Sciences
Valuation $100–250M Last recorded · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Guide Therapeutics and the history behind them.

At a glance

Status
Acquired
Founded
2018
Headquarters
Tucker, United States
Employees
1
Open positions
None listed
Dealroom signal
0.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Gene Therapy, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
b2b
Links
LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Feb 2021 $120M $120M Beam Therapeutics —
EARLY VCEquity / VC Aug 2020 $5.9M $23M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Guide Therapeutics website traffic

Latest recorded traffic for Guide Therapeutics is 130 monthly website visits, down 63.9% over the last three months. Guide Therapeutics's team grew 0% over the past year.

Latest monthly visits130 3-month web change-63.9% 1-year team growth0%
Monthly website visitsOct 2020–Oct 2023
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
RznomicsDeveloping RNA-based gene therapies targeting cancer and rare diseases Yongin-si, South Korea Operational 18 $68M $592M
Entos PharmaceuticalsDeveloping next-generation genetic medicines using their proprietary Fusogenix drug delivery platform Edmonton, Canada Operational
ArgenTagBarcoding kits and software for long-read seq | ArgenTAG New York City, United States Operational
MetagenomiDiscovering the next generation of gene-editing systems for use in treating genetic diseases Emeryville, United States Operational
Dyno TherapeuticsUtilizing next-gen DNA technologies and machine learning to engineer AAV capsids for effective delivery of gene therapies Watertown, United States Operational
Nucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine Oxford, United Kingdom Operational
FemtogenixDNA-interactive payloads for antibody-drug conjugates St Albans, United Kingdom Operational
NapigenA biotech company that addresses novel genome engineering of various organisms such as plants, microbes and animals Wilmington, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors3 additional known investors

  • Beam Therapeutics
  • University of California, Los Angeles
  • GV

Talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Tucker HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Guide Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Guide Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.